Riskpilot← Back to searchSign inGet full accessMedirox Aktiebolag
ABDissolvedOrg 5565524054Manufacture of other chemical products n.e.c. · NACE 2059Est. 19985 employees
Revenue 2022
SEK 32,6M
-24% vs 2021
EBITDA margin
23.7%
-21% vs 2021
Equity ratio
89.7%
Financial strength
Net profit 2022
SEK 32K
-99% vs 2021
| Revenue | SEK 32,6M | -24% |
| EBITDA | SEK 7,7M | -21% |
| Net profit | SEK 32K | -99% |
| Total assets | SEK 28,3M | -22% |
| Equity | SEK 25,4M | +0% |
| Employees | 5 | — |
Legal name
Medirox Aktiebolag
Org number
5565524054
Legal form
Aktiebolag
NACE code
2059 · Manufacture of other chemical products n.e.c.
Founded
29 januari 1998
Share capital
SEK 500 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Conradsson, Johan Fredrik Kristiansson, Erik Richard
Company purpose
Bolaget ska bedriva forskning, utveckling, tillverkning och försäljning av produkter inom rutinhemostasdiagnostik och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 39 532 | 41 936 | 36 319 | 43 084 | 32 583 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −116 | −797 | −2 849 | 9 805 | 7 728 |
| Depreciation & amort. | −1 575 | −1 509 | −1 781 | −2 062 | −782 |
| EBIT | −1 691 | −2 306 | −4 630 | 7 743 | 6 946 |
| Net financials | −10 | −141 | −306 | −198 | −4 |
| Profit before tax | 1 354 | 853 | −36 | 5 045 | 42 |
| Tax | −308 | −218 | −1 | −1 041 | −10 |
| Net profit | 1 046 | 635 | −37 | 4 004 | 32 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 30 098 | 41 145 | 36 828 | 36 066 | 28 276 |
| Equity | 20 719 | 21 354 | 21 317 | 25 321 | 25 353 |
| Long-term debt | 0 | 14 613 | 12 419 | 0 | 0 |
| Short-term debt | 6 079 | 5 178 | 3 092 | 10 745 | 2 923 |
| Total debt | 6 079 | 19 791 | 15 511 | 10 745 | 2 923 |
EBITDA margin
23.7%
This company
15.8%
Market median
+50% vs market
20182022
Equity ratio
89.7%
This company
38.2%
Market median
+135% vs market
20182022
Return on equity
0.1%
This company
18.4%
Market median
-99% vs market
20182022
Net profit margin
0.1%
This company
8.1%
Market median
-99% vs market
20182022
Asset turnover
1.15×
This company
1.12×
Market median
+3% vs market
20182022
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20182022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
RA Chief Executive Officer | Chief Executive Officer | 2021 |
JF External Signatory | External Signatory | 2022 |
JA Chief Auditor | Chief Auditor | 2022 |
ER External Signatory | External Signatory | 2022 |
| Former (3) | ||
CL External Signatory | External Signatory | 2023 – 2023 |
JM Chief Auditor | Chief Auditor | 2023 – 2023 |
CG Chief Auditor | Chief Auditor | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2021 | |
| Former (4) | ||
| Deputy Board Member | 2023 – 2023 | |
| Chairman | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nordic Biomarker Holding ABNordic Biomarker Bidco ABNordic Biomarker AB
Medirox Aktiebolag (this company)Board members of Medirox Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Cecilia Linnea Waldehorn | External Signatory | 0 companies |
| Johanna Margareta Eklöf | Chief Auditor | 0 companies |
| Carl Gustaf Mikael Fredstrand | Chief Auditor | 0 companies |
| Rikard Albert Rodén | Chief Executive Officer | 0 companies |
| Johan Fredrik Conradsson | External Signatory | 0 companies |
| Johan Anders Pettersson | Chief Auditor | 0 companies |
| Erik Richard Kristiansson | External Signatory | 0 companies |
| Anna Katharina Gimlander | Deputy Board Member | 0 companies |
| Eva Kristina Isaksson | Deputy Board Member | 0 companies |
| Bill Tunbrant | Chairman | 0 companies |
| Bernt Gunnar Pohl | Board of Directors | 0 companies |
| Claes Gustav Tyko Blanche | Board of Directors | 0 companies |